KL Clinical Monitoring ApS
CVR 45248674 · Private limited company (ApS) · Active · Medium risk
KL Clinical Monitoring ApS is a Private limited company (ApS), founded on , based in Aalborg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.7% over the next 12 months, which is 1.2 times the average for Danish companies. 1 annual report has been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 26k and a net result of DKK -14k. CEO: Kristian Lund.
Bankruptcy risk for KL Clinical Monitoring ApS
1.2 × the average (1.41%) · higher risk than 81% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45248674
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- c/o Kristian Lund, Davids Alle 46
9000 Aalborg - Municipality
- Aalborg
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 1 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 78.7% |
| Current ratio | 469% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 0 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -17k | – |
| Net profit | DKK -14k | – |
| Equity | DKK 26k | DKK 40k |
| Total assets | DKK 33k | – |
| Cash | DKK 29k | – |
| Short-term debt | DKK 6,999 | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 28 Nov 2024 – 31 Dec 2025 | 197 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Kristian Lund | Current | |
| Owner (100%) | Kristian Lund | Current | |
| Founder | Kristian Lund | Current |
Address history (0 moves)
| c/o Kristian Lund, Davids Alle 46, 9000 Aalborg |
Similar companies in Aalborg
- TeraJoule ApS Aalborg SØ
- Whitebox AI ApS Aalborg SØ
- Steeper Energy Technologies ApS Aalborg Øst
- NomoMedical ApS Aalborg SV
- Nordic Naval Edge ApS Aalborg
- Sierra Sailing Boats ApS Aalborg
- PED Insight ApS Aalborg
- Nordic Passive ApS Nibe
- Maternify ApS Aalborg
- SMPL Robotic Systems (Denmark) ApS Aalborg Øst
- ParsNord Thermal Comfort ApS Aalborg Øst
- BIOX ApS Aalborg Øst
Questions and answers about KL Clinical Monitoring ApS
Has KL Clinical Monitoring ApS gone bankrupt?
No, KL Clinical Monitoring ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of KL Clinical Monitoring ApS?
Our model estimates a bankruptcy risk of 1.7% over the next 12 months (medium risk), which is 1.2 times the average for Danish companies.
Who is the CEO of KL Clinical Monitoring ApS?
Kristian Lund is the CEO of KL Clinical Monitoring ApS.
When was KL Clinical Monitoring ApS founded?
KL Clinical Monitoring ApS was founded on 28 November 2024.
What is the equity of KL Clinical Monitoring ApS?
Equity was DKK 26k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.